The Archive · 4 posts
Innovating treatments for a healthier future! 🧬 Arecor Therapeutics (AREC) is advancing health with cutting-edge therapeutic solutions. 💊
Arecor's 2025 results showcase advances in diabetes with AT278 insulin nearing Phase 2 and oral peptide delivery progress, extending cash runway to 2027.
April 13, 2026
Showing 3 of 4 posts
JoshuaSeptember 25, 2025
Arecor & Skye Bioscience partner to develop nimacimab, an obesity drug with improved formulation & less frequent dosing via Arestat™ tech.
JoshuaMay 19, 2025
Arecor's diabetes breakthrough AT278 & oral peptide tech drive 2024 growth. Phase I success, partnerships & biopharma innovation.
JoshuaApril 22, 2025
April 22, 2025